Korean Drug Co., Ltd. (KOSDAQ:014570)
3,855.00
-155.00 (-3.87%)
At close: May 11, 2026
Korean Drug Market Cap
Korean Drug has a market cap or net worth of 42.07 billion as of May 11, 2026. Its market cap has decreased by -17.89% in one year.
Market Cap
42.07B
Enterprise Value
12.13B
Revenue
62.51B
Ranking
n/a
PE Ratio
6.46
Stock Price
3,855.00
Market Cap Chart
Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 42.07B, an increase of 235.45%. That is a compound annual growth rate of 5.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 43.76B | -6.74% |
| Dec 30, 2025 | 46.92B | -6.42% |
| Dec 30, 2024 | 50.14B | -36.00% |
| Dec 28, 2023 | 78.35B | -8.30% |
| Dec 29, 2022 | 85.44B | -12.32% |
| Dec 30, 2021 | 97.44B | -13.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hwail Pharmaceutical | 67.85B |
| BL Pharmtech | 62.66B |
| Jin Yang Pharmaceutical | 61.58B |
| Korea Arlico Pharm | 53.26B |
| RP Bio | 53.21B |
| Kyung Nam Pharm | 52.05B |
| Eagle Veterinary Technology Co.,Ltd | 50.06B |
| HLscience | 42.02B |